Michael Polansky is training an AI model on skin that’s still alive
Michael Polansky — better known publicly as Lady Gaga's partner and a former top deputy to Sean Parker — has quietly spent years building an AI-driven startup that keeps living human skin tissue alive for weeks outside the body to discover new skincare compounds, and is only now going public about it.
Places named in this report: San Francisco, New York, Paris
Exact coordinates
san francisco: 37.770, -122.420
new york: 40.710, -74.010
paris: 48.860, 2.350
Read it at TechCrunch See this on the map
What might happen next? AI-generated
These scenarios are written by an AI language model from the headline and summary above. They are not predictions from the newsroom, and they are not evidence of anything. Every one is given a deadline and checked against later coverage, and the score is published on the ledger — including the ones that miss.
-
Unresolved 45% Strategic Seed Funding Launch
Polansky successfully pitches the technology to a major venture capital firm or biotech conglomerate, leading to a rapid, high-profile funding announcement. This validates the early science and accelerates immediate commercialization efforts within the industry.
Watch for: A press release announces a $XX million Series A funding round for the startup. · A representative from a major pharmaceutical company issues a statement of 'keen interest' in the skin tissue technology.
-
Unresolved 30% Regulatory Scrutiny & Public Debate
The unique nature of 'living skin' AI triggers immediate ethical and FDA/EMA concerns. Regulatory bodies issue a formal inquiry or public advisory regarding the use of bio-materials in commercial AI training.
Watch for: The FDA issues a public warning or holds a virtual briefing regarding the bio-material use. · A prominent bioethicist publishes a widely cited op-ed criticizing the methodology within the first two weeks.
-
Unresolved 15% Academic Partnership Pivot
Faced with high development costs and regulatory hurdles, Polansky secures a partnership with a prestigious university's bioscience department. This shifts the immediate focus from commercial sales to collaborative R&D validation.
Watch for: The startup announces a formal research agreement with a specific named university. · A publication appears in a peer-reviewed journal detailing preliminary, ethically vetted results from the tissue model.
-
Unresolved 10% Niche Consumer Pre-Sale Focus (Counter-Intuitive)
Instead of targeting large biotech firms, Polansky bypasses traditional venture capital and launches a highly exclusive, extremely high-end subscription service for luxury brands. This avoids institutional scrutiny by staying small and secretive.
Watch for: A single, unnamed luxury cosmetic brand publicly announces a partnership with Polansky's startup. · The company opens a 'private waitlist' on their website, advertising a $10,000 entry fee.
Generated by gemma-4-E4B-it-qat-UD-Q4_K_XL.gguf
on 2026-08-22. Checked against later coverage after 2026-08-29.
See how these forecasts score.
ForecastGeo shows the headline and summary published by the newsroom and places the story on a map. The full article lives at the source.